PacBio Files 10-K, Details 2023 Performance
Ticker: PACB · Form: 10-K · Filed: 2024-02-28T00:00:00.000Z
Sentiment: neutral
Topics: earnings, 10-K, financial-report
TL;DR
**PacBio's 10-K is out, giving a full financial picture for 2023, including product and service revenues.**
AI Summary
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. filed its 10-K on February 28, 2024, for the fiscal year ending December 31, 2023. The company, a Large Accelerated Filer, reported product revenue for 2023, 2022, and 2021, alongside service and other revenue for the same periods. The filing also details common stock and additional paid-in capital as of December 31, 2020.
Why It Matters
This filing provides a comprehensive look into Pacific Biosciences' financial health and operational performance, crucial for investors to assess its future prospects in the laboratory analytical instruments sector.
Risk Assessment
Risk Level: medium — The filing provides financial data but lacks specific risk factors or forward-looking statements in the provided snippet to fully assess risk beyond general market and operational risks for a company in this sector.
Key Numbers
- 2023-12-31 — Fiscal Year End (Latest fiscal year reported)
- 105 — Public Document Count (Number of documents in the filing)
- 001-34899 — SEC File Number (Company's SEC registration number)
- 3826 — SIC Code (Industry classification for Laboratory Analytical Instruments)
- 2023 — Product Revenue Year (Year for which product revenue is reported)
Key Players & Entities
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — Filer of 10-K
- December 31, 2023 (date) — Conformed period of report end date
- February 28, 2024 (date) — Filed as of date
- Menlo Park, CA (company) — Business address location
- 0001299130 (company) — Central Index Key (CIK)
FAQ
What is the primary business of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. according to its SIC code?
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s primary business falls under the Standard Industrial Classification (SIC) code 3826, which corresponds to Laboratory Analytical Instruments.
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted to the SEC on February 28, 2024, as indicated by the 'FILED AS OF DATE'.
What is the fiscal year end for the reported period in this 10-K?
The conformed period of report for this 10-K ended on December 31, 2023.
What type of filer is PACIFIC BIOSCIENCES OF CALIFORNIA, INC.?
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is categorized as a 'Large Accelerated Filer'.
What types of revenue are specifically mentioned in the filing for the reported periods?
The filing specifically mentions 'ProductMember' revenue and 'ServiceAndOtherMember' revenue for the periods 2023, 2022, and 2021.
From the Filing
0001299130-24-000054.txt : 20240228 0001299130-24-000054.hdr.sgml : 20240228 20240228162825 ACCESSION NUMBER: 0001299130-24-000054 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 105 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 24695895 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 10-K 1 pacb-20231231.htm 10-K pacb-20231231 FY 0001299130 False 2023 Large Accelerated Filer http://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 0.0229885 0.046512 0001299130 2023-01-01 2023-12-31 0001299130 2023-06-30 iso4217:USD 0001299130 2024-01-31 xbrli:shares 0001299130 2023-12-31 0001299130 2022-12-31 iso4217:USD xbrli:shares 0001299130 us-gaap:ProductMember 2023-01-01 2023-12-31 0001299130 us-gaap:ProductMember 2022-01-01 2022-12-31 0001299130 us-gaap:ProductMember 2021-01-01 2021-12-31 0001299130 pacb:ServiceAndOtherMember 2023-01-01 2023-12-31 0001299130 pacb:ServiceAndOtherMember 2022-01-01 2022-12-31 0001299130 pacb:ServiceAndOtherMember 2021-01-01 2021-12-31 0001299130 2022-01-01 2022-12-31 0001299130 2021-01-01 2021-12-31 0001299130 us-gaap:CommonStockMember 2020-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001299130 us-gaap:RetainedEarningsMember 2020-12-31 0001299130 2020-12-31 0001299130 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001299130 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001299130 us-gaap:CommonStockMember 2021-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001299130 us-gaap:RetainedEarningsMember 2021-12-31 0001299130 2021-12-31 0001299130 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001299130 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001299130 us-gaap:CommonStockMember 2022-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001299130 us-gaap:RetainedEarningsMember 2022-12-31 0001299130 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001299130 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001299130 us-gaap:CommonStockMember 2023-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001299130 us-gaap:RetainedEarningsMember 2023-12-31 0001299130 pacb:CirculomicsIncMember 2023-01-01 2023-12-31 0001299130 pacb:CirculomicsIncMember 2022-01-01 2022-12-31 0001299130 pacb:CirculomicsIncMember 2021-01-01 2021-12-31 0001299130 pacb:AptonAndOmniomeMember 2023-01-01 2023-12-31 0001299130 pacb:AptonAndOmniomeMember 2